The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

Introduction: Smoking has a negative impact on survival of HNSCC patients. In addition, smoking is associated with the prevalence of co-morbidities and, thus, it may be assumed that not smoking per se but co-morbidities impact the course of therapy in terms of lower compliance and dose-reduction. Ho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Fazel, Asita, Quabius, Elgar Susanne, Fabian, Alexander, Schleicher, Thilo, Kress, Konstantin, Laudien, Martin, Huber, Karen, Herzog, Arved, Gonzales Donate, Mireia, Hoffmann, Markus
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7105812/
https://ncbi.nlm.nih.gov/pubmed/32266158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00398
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars